⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24250830 | 0.95 | — | — | |
| SCHEMBL15277279 | 0.75 | — | — | |
| SCHEMBL383738 | 0.75 | — | — | |
| SCHEMBL15277316 | 0.75 | — | — | |
| SCHEMBL8506053 | 0.72 | — | — | |
| SCHEMBL15277289 | 0.72 | — | — | |
| SCHEMBL9293579 | 0.72 | — | — | |
| SCHEMBL62080 | 0.70 | — | — | |
| SCHEMBL19649 | 0.70 | — | — | |
| SCHEMBL8927970 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731703-A1 | LINEAR POLYAMINES HAVING A LONG CARBON CHAIN, METHOD FOR PRODUCING SAME, AND USES THEREOF | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2026-04-29 | — | — | EP | claimed |
| WO-2024261162-A1 | LINEAR POLYAMINES HAVING A LONG CARBON CHAIN, METHOD FOR PRODUCING SAME, AND USES THEREOF | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2024-12-26 | — | — | WO | claimed |
| EP-4731703-A1 | LINEAR POLYAMINES HAVING A LONG CARBON CHAIN, METHOD FOR PRODUCING SAME, AND USES THEREOF | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2026-04-29 | — | — | EP | disclosed |
| CN-119866338-A | Tyrosine kinase 2 inhibitors and uses thereof | 渤健马萨诸塞州股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119301113-A | Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024261162-A1 | LINEAR POLYAMINES HAVING A LONG CARBON CHAIN, METHOD FOR PRODUCING SAME, AND USES THEREOF | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2024-12-26 | — | — | WO | disclosed |
| CN-112566906-B | Substituted quinazolinone derivatives and their use as positive allosteric modulators of MGLUR4 | 多曼治疗学公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118251389-A | Pyridyl derivatives as sodium channel activators | 泽农医药公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118043308-A | Bond formation method based on coupling reaction | 中外制药株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-117794898-A | 3-pyrrolylsulfonamide compounds as GPR17 antagonists | 瑞文德医疗公众有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-113039182-B | Inhibitors of YAP/TAZ-TEAD interactions and their use in cancer treatment | 伊文蒂瓦公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117561058-A | CDK2 inhibitors and methods of use thereof | 塞迪拉治疗股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-111936503-B | Oxazine monoacylglycerol lipase (MAGL) inhibitors | 豪夫迈·罗氏有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116547287-A | Inhibitors of APOL1 and methods of use thereof | 弗特克斯药品有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-116507608-A | Compounds, compositions, and methods | 戴纳立制药公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116096723-A | Heterocyclic compounds useful as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-114401969-A | Heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114401968-A | Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors | 豪夫迈·罗氏有限公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114364684-A | Heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-114269755-A | 4,4A,5,7,8, 8A-hexapyrido [4,3-B ] [1,4] oxazin-3-one compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2022-04-01 | — | — | CN | disclosed |